WASHINGTON, D.C. – Tomorrow, the House Appropriations Committee is scheduled to consider the draft FY26 appropriations bill approved on September 2nd by the House Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies. The bill includes an increase in funding for cancer research and cancer prevention and control programs.
The House spending bill includes: $48 billion for the National Institutes of Health (NIH), which is a $99 million increase in base level funding from FY25, including $7.272 billion for the National Cancer Institute (NCI), which is a $48 million increase over last year’s funding bill, and a $7.5 million increase for cancer prevention programs at the Centers for Disease Control and Prevention (CDC) for a total of $417.5 million. However, the bill also includes the elimination of $247 million for Tobacco Prevention and Control, and a $555 million cut for the Advanced Research Projects Agency for Health (ARPA-H).
In response, Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN) released the following statement:
“We are pleased to see the House Appropriations Committee provide increases for cancer research, an investment that will fuel groundbreaking advances in how we detect, treat and, ultimately, end cancer as we know it, for everyone. But we know the work is far from finished.
“Congress must continue to make cancer a top priority so we can build on this progress and ensure that every person, in every community, benefits from these lifesaving breakthroughs. As the appropriations process continues, we call on Congress to work in a bipartisan manner to provide the highest possible increases for cancer research and prevention and pass a year-long spending bill as soon as possible. By taking this vital step forward, we can transform the future of cancer care for all.”